Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

10d ago, source: Zacks.com on MSN

Shares of cancer-biotech Janux Therapeutics, Inc. JANX have surged close to 50% in the past week, following a report issued ...

Which Is a Better Investment, Janux Therapeutics Inc or BIO-TECHNE Corp Stock?

6d ago, source: American Association of Individual Investors

Learn more about whether Janux Therapeutics Inc or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor grades, ...

Here’s Why Janux Therapeutics Inc (NASDAQ: JANX) Is A Good Stock To Buy Right Now

2d ago, source:

Currently, records show that 46.25 million of the company’s shares remain outstanding. The insiders hold 33.35% of ...

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

on MSN ago, source:

Janux Therapeutics Inc (NASDAQ:JANX) shares are trading higher following Wednesday’s reports suggesting the company is ...

JANX Janux Therapeutics, Inc.

16d ago, source: Seeking Alpha

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr ...

Commit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using Options

22d ago, source: Nasdaq

Investors eyeing a purchase of Janux Therapeutics Inc (Symbol: JANX) shares, but tentative about paying the going market price of $35.70/share, might benefit from considering selling puts among ...

Janux Therapeutics Inc (JANX) Shares Soar Above 1-Year High

10d ago, source: newsheater

Reardon Tighe, the Acting Chief Financial Officer of Janux Therapeutics Inc, purchase 849,854 shares at $5.87 during a trade that took place back on Nov 13 ’23, which means that Reardon Tighe is ...

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday

on MSN ago, source:

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc.

Janux Therapeutics, Inc. (JANX)

6d ago, source: Yahoo Finance

2023--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its ...

Janux Therapeutics Inc Ordinary Shares JANX

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...